Key Events This Week
27 Jul: MarketsMOJO upgrades Lincoln Pharmaceuticals Ltd to Hold on technical and valuation improvements
31 Jul: Technical momentum shifts to sideways trend amid mixed indicator signals
31 Jul: Week closes at Rs.579.10, down 0.48% despite Sensex gains

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-07-31 08:00:37Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse.
Read full news article
Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements
2026-07-28 08:11:27Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some lingering challenges. The micro-cap pharmaceutical company’s recent performance and outlook have prompted analysts to revise their stance, signalling cautious optimism for investors.
Read full news articleLincoln Pharmaceuticals Falls 2.19%: 3 Key Factors Driving the Week’s Decline
2026-07-26 15:00:05
Key Events This Week
20 Jul: Stock opens at ₹598.65, modest gain despite flat Sensex
22 Jul: Sharp decline to ₹579.00 amid technical and financial concerns
23 Jul: Downgrade to Sell rating announced; technical momentum shifts
24 Jul: Mild recovery to ₹581.90 with mixed technical signals

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-07-24 08:00:54Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, a detailed analysis of key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveals a complex picture, with mixed signals that warrant cautious interpretation by investors.
Read full news article
Lincoln Pharmaceuticals Downgraded to Sell Amid Technical and Financial Concerns
2026-07-23 08:05:48Lincoln Pharmaceuticals Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 22 Jul 2026, reflecting a reassessment of its quality, valuation, financial trend, and technical outlook. Despite some long-term return strengths, the company faces challenges in growth momentum and technical indicators, prompting a more cautious stance from investors.
Read full news article
Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-07-23 08:00:57Lincoln Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 22 July 2026. The stock’s recent price action and technical indicators reveal a complex picture of mixed signals, suggesting caution for investors amid sideways trends and bearish undertones.
Read full news articleBoard Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.
06-Aug-2026 | Source : BSELincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Lincoln Pharmaceuticals Ltd has Informed BSE that the meeting of the Board of Directors of the Company is Scheduled on 13/08/2026 Inter alia to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jul-2026 | Source : BSEPursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended June 30 2026.
Closure of Trading Window
24-Jun-2026 | Source : BSEIntimation of Trading Window Closure for the Quarter ended June 30 2026.
Corporate Actions
13 Aug 2026
Lincoln Pharmaceuticals Ltd has declared 18% dividend, ex-date: 12 Sep 25
Lincoln Pharmaceuticals Ltd has announced 10:2 stock split, ex-date: 19 Mar 09
No Bonus history available
No Rights history available







